Article Data

  • Views 1979
  • Dowloads 121

Case Reports

Open Access

Isolated recurrence of early-stage cervical cancer in the abdominal wall with suboptimal surgery

  • E. Yilmaz1,*,
  • E. I. Coskun1
  • C. Koc2
  • N. Sahin3
  • B. Isik2
  • B. Ciplak1

1Inonu University Turgut Ozal Medical Center Obstetrics and Gynecology Department, Malatya, Turkey

2Inonu University Turgut Ozal Medical Center General Surgery Department, Malatya, Turkey

3Inonu University Turgut Ozal Medical Center Pathology Department, Malatya, Turkey

DOI: 10.12892/ejgo3884.2018 Vol.39,Issue 3,June 2018 pp.485-487

Published: 10 June 2018

*Corresponding Author(s): E. Yilmaz E-mail: ercanyilmazgyn@yahoo.com

Abstract

In this report, the authors present the case of a 47-year-old woman with an isolated recurrence of early-stage cervical cancer treated with suboptimal surgery of the abdominal wall and that subsequently underwent radiotherapy.

Keywords

Cervix, Cancer, Recurrence, Hysterectomy, Abdominal wall.

Cite and Share

E. Yilmaz,E. I. Coskun,C. Koc,N. Sahin,B. Isik,B. Ciplak. Isolated recurrence of early-stage cervical cancer in the abdominal wall with suboptimal surgery. European Journal of Gynaecological Oncology. 2018. 39(3);485-487.

References

[1] Franco E.L., Schlecht N.F., Saslow D.: “The epidemiology of cervical cancer”. Cancer J., 2003, 9, 348

[2] Sonoda Y., Abu-Rustum N.R., Gemignani N.L., Chi D.S., Brown C.L., Poynor E.A., et al.: “A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible?” Gynecol. Oncol., 2004, 95, 534.

[3] Castellsague X.: “Natural history and epidemiology of HPV infection and cervical cancer”. Gynecol. Oncol., 2008, 110, 4.

[4] Dizon D.S., Mackay H.J., Thomas G.M., Werner T.L., Kohn E.C., Hess D., et al.: “State of the science in cervical cancer: where we are today and where we need to go”. Cancer, 2014, 120, 2282.

[5] Padhani A.R.: “Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions”. J. Magn. Reson. Imaging, 2002, 16, 407.

[6] Gray H.J.: “Primary management of early stage cervical cancer (IA1-IB) and appropriate selection of adjuvant therapy”. J. Natl. Compr. Canc. Netw., 2008, 6, 47.

[7] Gaducci A., Teti G., Barsotti C., Tana R., Fanucchi A., Orlandini C., et al.: “Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin based neoadjuvant chemotherapy followed by radical hysterectomy”. Anticancer Res., 2010, 30, 201.

[8] Wang J., Wang T., Yang Y.Y., Chai Y.L., Shi F., Liu Z.I.: “Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer”. Mol. Clin. Oncol., 2015, 3, 363.

[9] Lataifeh I., Jaradat I., Seoud M., Youssef B., Barahmeh S., Geara F.: “Survival outcome after radiation therapy for patients with early cervical carcinoma undergoing inadequate primary surgery”. Int. J. Gynecol. Cancer, 2014, 24, 124.

[10] Münstedt K., Johnson P., von Georgi R., Vahrson H., Tinneberg H.R.: Consequences of inadvertent, suboptimal primary surgery in carcinoma of the uterine cervix”. Gynecol. Oncol., 2004, 94, 515.

Submission Turnaround Time

Top